Results 151 to 160 of about 10,088 (191)

<i>In vitro</i> study of ethanol production, ethanol tolerance, and antimicrobial susceptibility of gut microbes associated with liver diseases. [PDF]

open access: yesGut Microbes Rep
Idrissa Abdoulaye A   +17 more
europepmc   +1 more source

Rifaximin Treatment in Hepatic Encephalopathy [PDF]

open access: yesNew England Journal of Medicine, 2010
Background Hepatic encephalopathy is a chronically debilitating complication of hepatic cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the treatment of acute hepatic encephalopathy, but its efficacy for ...
Arun Sanyal   +2 more
exaly   +2 more sources

Rifaximin

Hospital Pharmacy, 2010
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Dennis J. Cada   +2 more
  +4 more sources

Is Generic Rifaximin Still a Poorly Absorbed Antibiotic? A Comparison of Branded and Generic Formulations in Healthy Volunteers

open access: yesPharmacological Research, 2014
Rifaximin is an antibiotic, locally acting in the gastrointestinal tract, which may exist in different crystal as well as amorphous forms. The branded rifaximin formulation contains the polymorph rifaximin-α, whose systemic bioavailability is very ...
Carmelo SCARPIGNATO   +2 more
exaly   +3 more sources

Drug Therapy: Rifaximin

Hepatology, 2010
[No abstract available]
J. S. Bajaj, RIGGIO, Oliviero
openaire   +3 more sources

Rifaximin

Reactions Weekly, 2023
openaire   +2 more sources

Rifaximin

Reactions Weekly, 2009
openaire   +2 more sources

Home - About - Disclaimer - Privacy